Welcome to LookChem.com Sign In|Join Free

CAS

  • or

557-24-4

Post Buying Request

557-24-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

557-24-4 Usage

Description

Maleamic acid, also known as N-(hydroxymethyl)maleamic acid, is a dicarboxylic acid monoamide derived from maleamic acid. It is a solid compound with unique chemical properties that make it suitable for various applications in different industries.

Uses

Used in Pharmaceutical Industry:
Maleamic acid is used as an intermediate in the preparation of a new conjugated agent for the radioiodination of proteins. This application is significant because it allows for the development of new diagnostic and therapeutic agents that can be used in the medical field.
Used in Chemical Synthesis:
Due to its unique chemical properties, maleamic acid can be used as a building block in the synthesis of various complex organic compounds. This makes it a valuable reagent in the chemical industry for creating new molecules with specific functions and properties.
Used in Research and Development:
Maleamic acid can also be utilized in research and development settings to study its properties and potential applications. This can lead to the discovery of new uses and advancements in various fields, including pharmaceuticals, materials science, and biotechnology.

Purification Methods

Crystallise it from EtOH. [Beilstein 2 H 752, 2 II 646, 2 III 1927, 2 IV 1927.] IRRITANT.

Check Digit Verification of cas no

The CAS Registry Mumber 557-24-4 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,5 and 7 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 557-24:
(5*5)+(4*5)+(3*7)+(2*2)+(1*4)=74
74 % 10 = 4
So 557-24-4 is a valid CAS Registry Number.
InChI:InChI=1/C4H5NO3/c5-3(6)1-2-4(7)8/h1-2H,(H2,5,6)(H,7,8)/b2-1+

557-24-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name maleamic acid

1.2 Other means of identification

Product number -
Other names Maleamic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:557-24-4 SDS

557-24-4Relevant articles and documents

Daron et al.

, p. 895,896 (1966)

Three-Component Synthesis of Quinolines Based on Radical Cascade Visible-Light Photoredox Catalysis

Choi, Jun-Ho,Park, Cheol-Min

supporting information, p. 3553 - 3562 (2018/09/22)

Synthesis of highly substituted quinolines has been developed based on three-component radical cascade based on visible-light photoredox catalysis. This tandem coupling reaction has been coordinated to proceed with high chemoselectivity based on the differential electronic properties of coupling partners. Subjection of electron-rich β-aminoacrylates with electron-deficient halides and alkenes to the optimized conditions leads to the formation of quinolines in good yields after in situ oxidation of tetrahydroquinolines. Detailed mechanistic studies which reveal an unexpected reaction pathway is described. (Figure presented.).

METHODS FOR PRODUCING POLYASPARTIC ACID PRECURSOR POLYMER AND POLYASPARTIC ACID SALT

-

, (2012/12/14)

Disclosed are a method for producing a polyaspartic acid precursor polymer by polymerization using at least one kind selected from a product obtained from maleic anhydride and ammonia and, maleamic acid as a monomer, wherein at least part of carboxyl groups in the monomers are a tertiary amine salt; and an industrially inexpensive and simple method for producing a polyaspartic acid salt by treating the polyaspartic acid precursor polymer obtained by this method with a basic aqueous solution.

Nucleic acid triggered catalytic drug and probe release

-

, (2008/06/13)

The present invention provides methods and combinations of compositions for the modulation of diseases caused by a subject possessing a disease-specific nucleic acid sequence. Included are methods for the treatment, prevention and/or inhibition of the diseases by administering a combination of a prodrug component, drug and catalytic component such that the drug is catalytically released when contacting the combination to the disease-specific nucleic acid sequence.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 557-24-4